BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24685478)

  • 1. Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis.
    Shim SH; Lee SJ; Kim SN
    Eur J Cancer; 2014 Jun; 50(9):1628-37. PubMed ID: 24685478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: A systematic review and meta-analysis.
    Wang S; Wang Y; Xu J; Chen Y
    Medicine (Baltimore); 2017 Apr; 96(14):e6556. PubMed ID: 28383429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone Replacement Therapy in Post-Menopause Hormone-Dependent Gynecological Cancer Patients: A Narrative Review.
    Villa P; Bounous VE; Amar ID; Bernardini F; Giorgi M; Attianese D; Ferrero A; D'Oria M; Scambia G
    J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of menopausal symptoms in women with gynecologic cancers.
    Del Carmen MG; Rice LW
    Gynecol Oncol; 2017 Aug; 146(2):427-435. PubMed ID: 28625396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial cancer: a review and current management strategies: part II.
    ; Burke WM; Orr J; Leitao M; Salom E; Gehrig P; Olawaiye AB; Brewer M; Boruta D; Herzog TJ; Shahin FA;
    Gynecol Oncol; 2014 Aug; 134(2):393-402. PubMed ID: 24929052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.
    Shao R; Li X; Feng Y; Lin JF; Billig H
    J Exp Clin Cancer Res; 2014 May; 33(1):41. PubMed ID: 24887156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy in cancer survivors: Utopia?
    Angioli R; Luvero D; Armento G; Capriglione S; Plotti F; Scaletta G; Lopez S; Montera R; Gatti A; Serra GB; Benedetti Panici P; Terranova C
    Crit Rev Oncol Hematol; 2018 Apr; 124():51-60. PubMed ID: 29548486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy after treatment for a gynaecological malignancy.
    O'Donnell RL; Clement KM; Edmondson RJ
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):32-41. PubMed ID: 26626038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
    Li D; Ding CY; Qiu LH
    Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Security of hormone replacement therapy among postoperative patients with endometrial carcinoma: a Meta-analysis].
    Wu F; Fan LM; Xu ZG; Cui MH
    Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(1):53-7. PubMed ID: 26792609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of climacteric symptoms in survivors of gynaecological cancer.
    Biglia N; Bounous VE; Sgro LG; D'Alonzo M; Gallo M
    Maturitas; 2015 Nov; 82(3):296-8. PubMed ID: 26341044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous HRT with oestrogen plus progestogen is linked to reduced risk of endometrial cancer.
    Mayor S
    BMJ; 2015 Dec; 351():h6627. PubMed ID: 26645093
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone replacement therapy for women previously treated for endometrial cancer.
    Edey KA; Rundle S; Hickey M
    Cochrane Database Syst Rev; 2018 May; 5(5):CD008830. PubMed ID: 29763969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
    Deli T; Orosz M; Jakab A
    Pathol Oncol Res; 2020 Jan; 26(1):63-78. PubMed ID: 30617760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and the risk of endometrial cancer: A systematic review.
    Sjögren LL; Mørch LS; Løkkegaard E
    Maturitas; 2016 Sep; 91():25-35. PubMed ID: 27451318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.
    Eeles RA; Morden JP; Gore M; Mansi J; Glees J; Wenczl M; Williams C; Kitchener H; Osborne R; Guthrie D; Harper P; Bliss JM
    J Clin Oncol; 2015 Dec; 33(35):4138-44. PubMed ID: 26417001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.
    Stuenkel CA; Davis SR; Gompel A; Lumsden MA; Murad MH; Pinkerton JV; Santen RJ
    J Clin Endocrinol Metab; 2015 Nov; 100(11):3975-4011. PubMed ID: 26444994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy after surgery for epithelial ovarian cancer.
    Saeaib N; Peeyananjarassri K; Liabsuetrakul T; Buhachat R; Myriokefalitaki E
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012559. PubMed ID: 31989588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of the 2023 Thai Menopause Society Clinical Practice Guideline on Menopausal Hormone Therapy.
    Chaikittisilpa S; Orprayoon N; Vallibhakara O; Vallibhakara SA; Tanmahasamut P; Somboonporn W; Rattanachaiyanont M; Techatraisak K; Jaisamrarn U
    J Menopausal Med; 2024 Apr; 30(1):24-36. PubMed ID: 38714491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Kotait M; Shea A; Nguyen JMV
    CMAJ; 2024 Apr; 196(14):E506-E507. PubMed ID: 38621775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.